AntiViral Research Center In the Department of Medicine

Welcome to the AVRC HQ

Innovation in HIV Research

The AntiViral Research Center (AVRC) HQ develops and conducts innovative research that enhances the quality and duration of life for people living with or affected by HIV infection and other infections of global significance. The award-winning research center is an established leader in San Diego’s HIV research community and is well known for its HIV testing programs. Internationally, the AVRC extends its research and education programs to Africa, Asia, and South America.


AVRC Community Liaison Marvin Hanashiro Receives 2019 UC San Diego Inclusive Excellence Award
Recipients of this award have been recognized for making outstanding contributions in the areas of inclusion, equity, diversity, and the UCSD Principles of Community during the year.
Stay in the Know with the 'Last Gift'
Study staff has started an e-newsletter to keep participants and providers informed on the latest HIV-cure research and study updates.
Lead the Way launches new media campaign
With a new media campaign, Lead the Way aims to get more San Diego residents tested for HIV
‘Testing for Tickets’ returns to Lead the Way SD on June 15, 2017
While supplies last, the annual program offers complimentary 2-day Pride Festival passes with each HIV test
A Transgender Woman's Perspective on HIV Research, Prevention, and Care
Dr. Gianella talks with Brooke Sullivan, a California-based transgender woman and HIV activist, about her transition, living with HIV, her experiences with activism, barriers to HIV prevention and care for transgender people, and taking part in clinical trials to enhance understanding of HIV research within this group.
PrEP in the Transgender Population: New Study to Examine Effects
Transgender women are a fast-growing and disenfranchised population of HIV-positive people in the United States, but few opportunities are available for transgender individuals to be involved in HIV research. Including the transgender community in HIV studies is necessary to design preventive and curative approaches that can be applied across the entire spectrum of genders.
ion theatre proudly announces a revival of the provocative Tony Award-winning "The Normal Heart" by Larry Kramer
Partners with San Diego service agencies to promote HIV/AIDS awareness and treatment
Novel Drug Combo Succeeds Against Multiple HCV Genotypes
No cases of virologic failure observed with ABT-493 plus ABT-530
Successful diagnosis of acute/early HIV infections may have contributed to fall in HIV incidence in San Diego
An HIV testing programme [The Early Test] targeting individuals with acute/early infection likely contributed to a decline in incident infections in San Diego after 2008, investigators report in Clinical Infectious Diseases.
An HIV Prevention Pill for Transgender Persons
UC launches first in the nation demonstration project
UC San Diego AVRC Hosts National HIV Scientists for 2015 Cure Conference
A collaborative HIV Cure Conference features presentations by researchers at the forefront of new cure advancements on June 16
‘Testing for Tickets’ Encourages HIV Testing, Offers Free LGBT Pride Festival Tickets
Innovative HIV testing campaign offers 250 free LGBT Pride Festival tickets to people who get tested starting June 15 and continuing until supplies run out
HIV Transmission Networks Mapped to Reduce Infection Rate
Susan Little, MD maps San Diego's HIV transmission network, identifies transmission "hot spots"
Treatment for HIV Should Start within Four Months of Infection
Study by AVRC researchers identifies optimum window for initiating antiretrovial therapy for CD-4+ T-cell recovery

External Resources: